SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
REPH
--
0.00%
--
Edited Transcript of REPH earnings conference call or presentation 11-May-20 12:00pm GMT
Thomson Reuters StreetEvents · 5d ago
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14)
Benzinga · 05/15 11:49
RECRO PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating Recro Pharma, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm
Business Wire · 05/13 17:44
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's morning session saw 81 companies set new 52-week lows.
Benzinga · 05/13 15:07
INVESTOR ALERT: Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Recro Pharma, Inc.
GlobeNewswire · 05/13 00:50
Oppenheimer Maintains Outperform on Recro Pharma, Lowers Price Target to $12
Oppenheimer maintains Recro Pharma (NASDAQ:REPH) with a Outperform and lowers the price target from $18 to $12.
Benzinga · 05/12 12:20
78 Biggest Movers From Yesterday
Gainers
Benzinga · 05/12 09:02
Recro Pharma, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton; Investors Who Lost Money Should Contact the Firm
GlobeNewswire · 05/11 22:13
Recro Pharma Inc (REPH) Q1 2020 Earnings Call Transcript
Motley Fool · 05/11 21:00
Investor Alert: Kaplan Fox Investigates Recro Pharma, Inc.
PR Newswire · 05/11 20:44
Mid-Afternoon Market Update: NASDAQ Rises Over 100 Points; Amneal Pharmaceuticals Shares Surge On Upbeat Results
Toward the end of trading Monday, the Dow traded down 0.11% to 24305.58 while the NASDAQ rose 1.17% to 9228. The S&P also rose, gaining 0.27% to 2,937.69.
Benzinga · 05/11 19:02
Recro Pharma down 41% on tough Q1, guidance cut
Recro Pharma (REPH -40.6%) Q1 results: Revenues: $21.8M (-13.1%). Net loss: ($7.7M); loss/share: ($0.33). Non-GAAP EBITDA: $2.7M. 2020 guidance: Revenue: $
seekingalpha · 05/11 18:56
AMC, CYTK, MT and SALT among midday movers
Seeking Alpha - Article · 05/11 16:40
54 Stocks Moving In Monday's Mid-Day Session
Gainers
Benzinga · 05/11 16:39
Mid-Day Market Update: Recro Pharma Falls After Q1 Results; MyoKardia Shares Climb
Midway through trading Monday, the Dow traded down 0.80% to 24135.84 while the NASDAQ rose 0.19% to 9138.42. The S&P also fell, dropping 0.42% to 2917.35.
Benzinga · 05/11 16:29
Recro Pharma, Inc.'s (REPH) CEO Gerri Henwood on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/11 14:46
Stocks That Hit 52-Week Lows On Monday
On Monday, 14 stocks hit new 52-week lows.
Benzinga · 05/11 14:43
Mid-Morning Market Update: Markets Mostly Lower; Cardinal Health Beats Q3 Estimates
Following the market opening Monday, the Dow traded down 0.83% to 24128.74 while the NASDAQ rose 0.19% to 9,138.91. The S&P also fell, dropping 0.52% to 2,914.59.
Benzinga · 05/11 14:15
Recap: Recro Pharma Q1 Earnings
Benzinga · 05/11 12:31
Recap: Recro Pharma Q1 Earnings
Shares of Recro Pharma (NASDAQ:REPH) fell 7.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 230.00% year over year to ($0.33), which missed the estimate of ($0.03).
Benzinga · 05/11 11:31